Free Trial

BioLife Solutions (BLFS) News Today

BioLife Solutions logo
$22.03 -1.27 (-5.45%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$22.74 +0.70 (+3.20%)
As of 06/13/2025 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why is BioLife Solutions Dropping Today?

BioLife Solutions, Inc. (NASDAQ:BLFS) shares moved lower today after a series of insider and major‐shareholder stock sales were disclosed. Investors are watching these transactions as potential bearish signals for the stock.

  • Major shareholder Casdin Partners Master Fund sold 1,000,000 shares at an average price of $23.80, trimming its stake by 11.48%.
  • EVP Aby J. Mathew sold 637 shares at $23.70 per share, reducing his position by 0.18%.
  • CFO Troy Wichterman sold 1,042 shares at $23.70 per share, a 0.56% reduction in his holdings.
  • CMO Todd Berard sold 362 shares at $23.70 per share, cutting his stake by 0.27%.
  • Director Karen A. Foster sold 320 shares at $23.70 per share, reducing her ownership by 0.16%.
  • Sarah Aebersold sold 235 shares at $23.70 per share, a 0.29% decrease in her position.
  • CTO Sean Werner sold 65 shares at $23.70 per share, trimming his stake by 0.23%.

All of these sales were disclosed via SEC filings and may reflect profit‐taking or shifting insider sentiment toward the current share price around the $23.70–$23.80 range.

Posted 22h agoAI Generated. May Contain Errors.

BLFS Latest News

BioLife Solutions, Inc. stock logo
GAMMA Investing LLC Has $2.20 Million Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
GAMMA Investing LLC grew its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 2,609.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 96,453 shares of the medical equipment provider's stock after purchasing an additional
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Major Shareholder Casdin Partners Master Fund, L Sells 1,000,000 Shares
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) major shareholder Casdin Partners Master Fund, L sold 1,000,000 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $23.80, for a total value of $23,800,000.00. Following the completion of the sale, the insider now owns 7,707,165 shares in the company, valued at approximately $183,430,527. The trade was a 11.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.
BioLife Solutions, Inc. stock logo
Aby J. Mathew Sells 637 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 637 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $23.70, for a total transaction of $15,096.90. Following the sale, the executive vice president now owns 353,118 shares in the company, valued at $8,368,896.60. This represents a 0.18% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $24,695.40 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 1,042 shares of BioLife Solutions stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $23.70, for a total transaction of $24,695.40. Following the sale, the chief financial officer now directly owns 186,685 shares in the company, valued at approximately $4,424,434.50. The trade was a 0.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
BioLife Solutions, Inc. stock logo
BioLife Solutions (NASDAQ:BLFS) Shares Up 9.2% - Time to Buy?
BioLife Solutions (NASDAQ:BLFS) Trading Up 9.2% - Here's Why
BioLife Solutions, Inc. stock logo
BioLife Solutions (NASDAQ:BLFS) Shares Down 5.2% - What's Next?
BioLife Solutions (NASDAQ:BLFS) Trading Down 5.2% - Time to Sell?
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells $11,701.66 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 521 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $22.46, for a total transaction of $11,701.66. Following the completion of the transaction, the executive vice president now owns 308,486 shares of the company's stock, valued at approximately $6,928,595.56. The trade was a 0.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $13,094.18 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 583 shares of the company's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $22.46, for a total transaction of $13,094.18. Following the completion of the sale, the chief financial officer now directly owns 187,727 shares in the company, valued at $4,216,348.42. This trade represents a 0.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
BioLife Solutions, Inc. stock logo
Kings Path Partners LLC Sells 13,100 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
Kings Path Partners LLC reduced its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 38.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,815 shares of the medical eq
BioLife Solutions, Inc. stock logo
HC Wainwright Predicts Weaker Earnings for BioLife Solutions
BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Stock analysts at HC Wainwright cut their Q3 2025 EPS estimates for BioLife Solutions in a report released on Tuesday, May 27th. HC Wainwright analyst Y. Chen now forecasts that the medical equipment provider will post earnings per share of ($
BioLife Solutions, Inc. stock logo
HC Wainwright Brokers Lower Earnings Estimates for BLFS
BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Equities research analysts at HC Wainwright reduced their Q3 2026 earnings per share estimates for BioLife Solutions in a research report issued on Tuesday, May 27th. HC Wainwright analyst Y. Chen now expects that the medical equipment provide
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Buy" by Brokerages
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has been given a consensus rating of "Buy" by the six brokerages that are covering the stock, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have
BioLife Solutions, Inc. stock logo
Bank of America Corp DE Reduces Stake in BioLife Solutions, Inc. (NASDAQ:BLFS)
Bank of America Corp DE cut its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 16.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 541,079 shares of the medical equi
BioLife Solutions, Inc. stock logo
BioLife Solutions (NASDAQ:BLFS) Cut to "Sell" at StockNews.com
StockNews.com lowered shares of BioLife Solutions from a "hold" rating to a "sell" rating in a research report on Wednesday.
BioLife Solutions, Inc. stock logo
Point72 Asset Management L.P. Invests $11.11 Million in BioLife Solutions, Inc. (NASDAQ:BLFS)
Point72 Asset Management L.P. purchased a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 428,099 shares of the medical equipment provide
BioLife Solutions, Inc. stock logo
Millennium Management LLC Has $29.73 Million Stock Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)
Millennium Management LLC grew its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 49.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,145,347 shares of the medical equipment provider's stock
BioLife Solutions, Inc. stock logo
Northern Trust Corp Has $10.67 Million Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)
Northern Trust Corp grew its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 7.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 411,033 shares of the medical equipment provider's stock after purchasi
BioLife Solutions, Inc. stock logo
BioLife Solutions (NASDAQ:BLFS) Given Buy Rating at HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $30.00 target price on shares of BioLife Solutions in a research report on Tuesday.
BioLife Solutions, Inc. stock logo
Brokers Set Expectations for BLFS Q3 Earnings
BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Analysts at Northland Capmk issued their Q3 2025 earnings per share estimates for BioLife Solutions in a report issued on Friday, May 9th. Northland Capmk analyst C. Byrnes forecasts that the medical equipment provider will post earnings of ($
BioLife Solutions, Inc. stock logo
BioLife Solutions (NASDAQ:BLFS) Posts Earnings Results, Beats Estimates By $0.07 EPS
BioLife Solutions (NASDAQ:BLFS - Get Free Report) posted its quarterly earnings results on Thursday. The medical equipment provider reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.07. BioLife Solutions had a negative net margin of 38.98% and a negative return on equity of 6.61%.
BioLife Solutions, Inc. stock logo
Granahan Investment Management LLC Sells 201,627 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
Granahan Investment Management LLC lowered its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 30.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 457,007 shares of the medical equipment provider's stock after selling 201,627 sh
BioLife Solutions, Inc. stock logo
Fred Alger Management LLC Purchases 16,274 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
Fred Alger Management LLC boosted its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 1.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,594,221 shares of the medical e
BioLife Solutions, Inc. stock logo
Caxton Associates LP Takes $314,000 Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
Caxton Associates LP bought a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 12,112 shares of the medical equipment provid
BioLife Solutions, Inc. stock logo
Dimensional Fund Advisors LP Purchases 40,416 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
Dimensional Fund Advisors LP increased its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 887,008 shares of the medical equipment pro
BioLife Solutions, Inc. stock logo
First Trust Advisors LP Makes New Investment in BioLife Solutions, Inc. (NASDAQ:BLFS)
First Trust Advisors LP bought a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 132,991 shares of the medical
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Sold by Renaissance Technologies LLC
Renaissance Technologies LLC trimmed its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 61.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,100 shares of the medical equipmen
BioLife Solutions, Inc. stock logo
BioLife Solutions (BLFS) Projected to Post Quarterly Earnings on Thursday
BioLife Solutions (NASDAQ:BLFS) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-biolife-solutions-inc-stock/)
BioLife Solutions, Inc. stock logo
Voya Investment Management LLC Sells 179,106 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
Voya Investment Management LLC lessened its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 20.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 682,603 shares of the medical equipment provider's stock after selling 179,1
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Average Recommendation of "Buy" from Brokerages
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has earned a consensus recommendation of "Buy" from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1 year price objective among br
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Purchased by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. lifted its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 18.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 198,695 shares of the medical equipment provider's stock after acquiring an addition
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Holdings Increased by Curi RMB Capital LLC
Curi RMB Capital LLC lifted its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 433,815 shares of the medical equipment provider's stock aft
BioLife Solutions, Inc. stock logo
Raymond James Financial Inc. Buys New Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
Raymond James Financial Inc. purchased a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 795,998 shares of the medical equipment provider's
BioLife Solutions, Inc. stock logo
Cramer Rosenthal Mcglynn LLC Has $23.51 Million Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)
Cramer Rosenthal Mcglynn LLC decreased its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 17.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 905,752 shares of the medical equipment pro
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Holdings Decreased by JPMorgan Chase & Co.
JPMorgan Chase & Co. reduced its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 8.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 253,585 shares of the medical
BioLife Solutions, Inc. stock logo
Portolan Capital Management LLC Decreases Stock Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)
Portolan Capital Management LLC reduced its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 67.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 137,299 shares of the medical equipment pr
BioLife Solutions, Inc. stock logo
Rockefeller Capital Management L.P. Has $21.33 Million Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
Rockefeller Capital Management L.P. lifted its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 40.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 821,764 shares of the medical equipment pro
Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

BLFS Media Mentions By Week

BLFS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLFS
News Sentiment

0.12

0.88

Average
Medical
News Sentiment

BLFS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLFS Articles
This Week

13

5

BLFS Articles
Average Week

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners